Evidence map›Paper›PMID 40904109›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025

Why do bacteria accumulate antiphage defence systems?

Tyler Clabby, Florian Tesson, Baptiste Gaborieau, Aude Bernheim

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Preface: the ecology and evolution of bacterial immune systems.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tyler ClabbyDepartment of Genetics and Genomics, Pasteur Institute, 75015 Paris, France.ORCID 0009-0000-3887-4510
Florian TessonDepartment of Genetics and Genomics, Pasteur Institute, 75015 Paris, France.ORCID 0000-0003-4038-1154
Baptiste GaborieauUniversité Paris Cité, INSERM, UMR 1137, IAME, Paris 75018, France.ORCID 0000-0002-9586-3014
Aude BernheimDepartment of Genetics and Genomics, Pasteur Institute, 75015 Paris, France.ORCID 0000-0003-0212-777X

Funding

European Research CouncilMSDAVENIRPasteur Institute
6 · The paper itself

Abstract

While it is well established that bacterial genomes encode multiple and diverse antiphage systems, the reasons for their co-occurrence and their heterogeneous distribution remain debated. This review examines why bacteria accumulate antiphage systems and how this influences phage-bacteria interactions, particularly in the context of phage therapy. Two main hypotheses may explain this phenomenon: (i) the pan-immunity hypothesis, which suggests that defence system accumulation provides protection against phage predation at the community level, and (ii) mobile genetic element (MGE) competition, where defence systems primarily protect intra-bacterial MGEs against other ones rather than the bacterial host itself. The ecological context also influences the distribution of antiphage systems, with defencee accumulation shaping phage-bacteria interactions in diverse communities but playing a lesser role at the species level, potentially explaining why multiple defences do not strongly limit phage host range in therapeutic settings. Finally, we address the challenges in understanding the drivers shaping the distribution of defence systems across bacterial genomes (expressions, costs, etc.) and their implications for elucidating the ecological role of defence systems and optimizing phage therapy strategies.This article is part of the discussion meeting issue 'The ecology and evolution of bacterial immune systems'.

Indexed as

BacteriaBacteriophagesPhage TherapyCRISPR-Cas SystemsEcologyGene Transfer, HorizontalInterspersed Repetitive Sequencesbacteriophagedefence systemshost rangemobile genetic elementsphage therapy

Identifiers

PMID40904109
PMCPMC12409364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.